{
  "guideline": {
    "id": "PA166184637",
    "name": "Annotation of FDA Label for oxymetazoline and tetracaine and BCHE, CYB5R3, G6PD",
    "objCls": "Label Annotation",
    "source": "FDA",
    "version": 6,
    "url": "https://www.pharmgkb.org/labelAnnotation/PA166184637",
    "relatedChemicals": [
      {
        "id": "PA166182885",
        "name": "oxymetazoline and tetracaine",
        "symbol": null
      }
    ],
    "relatedGenes": [
      {
        "id": "PA25294",
        "name": "butyrylcholinesterase",
        "symbol": "BCHE"
      },
      {
        "id": "PA27331",
        "name": "cytochrome b5 reductase 3",
        "symbol": "CYB5R3"
      },
      {
        "id": "PA28469",
        "name": "glucose-6-phosphate dehydrogenase",
        "symbol": "G6PD"
      }
    ],
    "recommendation": false
  },
  "recommendations": [
    {
      "id": "PA166312394",
      "name": "Recommendation Annotation PA166312394",
      "population": null,
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA166182885",
          "name": "oxymetazoline and tetracaine",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452216674,
        "html": "<p>&quot;Although all patients are at risk for methemoglobinemia, patients with glucose-6-phosphate dehydrogenase deficiency,  ... are more susceptible to developing clinical manifestations of the condition. If local anesthetics must be used in these patients, close monitoring for symptoms and signs of methemoglobinemia is recommended.&quot; See label for more information.</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "G6PD": "Deficient with CNSHA"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": true
    },
    {
      "id": "PA166315141",
      "name": "Recommendation Annotation PA166315141",
      "population": null,
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA166182885",
          "name": "oxymetazoline and tetracaine",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452245680,
        "html": "<p>&quot;Although all patients are at risk for methemoglobinemia, patients with glucose-6-phosphate dehydrogenase deficiency,  ... are more susceptible to developing clinical manifestations of the condition. If local anesthetics must be used in these patients, close monitoring for symptoms and signs of methemoglobinemia is recommended.&quot; See label for more information.</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "G6PD": "Variable"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": true
    },
    {
      "id": "PA166312395",
      "name": "Recommendation Annotation PA166312395",
      "population": null,
      "classification": null,
      "relatedChemicals": [
        {
          "id": "PA166182885",
          "name": "oxymetazoline and tetracaine",
          "symbol": null
        }
      ],
      "text": {
        "id": 1452216675,
        "html": "<p>&quot;Although all patients are at risk for methemoglobinemia, patients with glucose-6-phosphate dehydrogenase deficiency,  ... are more susceptible to developing clinical manifestations of the condition. If local anesthetics must be used in these patients, close monitoring for symptoms and signs of methemoglobinemia is recommended.&quot; See label for more information.</p>\n"
      },
      "implications": [],
      "lookupKey": {
        "G6PD": "Deficient"
      },
      "dosingInformation": false,
      "alternateDrugAvailable": false,
      "otherPrescribingGuidance": true
    }
  ],
  "citations": [
    {
      "pmid": null,
      "title": "Drugs@FDA: Drug Product oxymetazoline and tetracaine (NDA208032)",
      "authors": [],
      "journal": null,
      "year": -1,
      "_sameAs": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&varApplNo=208032"
    }
  ],
  "version": "2024-03-08-14-34"
}